[{"bbox": [90, 98, 370, 133], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [90, 169, 279, 203], "category": "Section-header", "text": "## Other expenses"}, {"bbox": [90, 233, 1563, 397], "category": "Text", "text": "Other expenses increased by 29.06% from ₹ 4913.78 lakhs in Fiscal 2024 to ₹ 6341.96 lakhs in Fiscal 2025. The main reason for increase in the other expenses is the business efficiency and product mix of the company on account of increase in the revenue, the company was able to achieve higher sales target by keeping the other expenses portion little low. There are certain expenses which are of fixed nature as well which remains approximate to same irrespective of the increase in the revenue. For details of other expenses refer to page 225."}, {"bbox": [90, 426, 257, 460], "category": "Section-header", "text": "## Tax Expenses"}, {"bbox": [90, 490, 1268, 524], "category": "Text", "text": "Increase in the tax expenses is on account of increase in the revenue and resulting profits of the company."}, {"bbox": [90, 553, 280, 584], "category": "Section-header", "text": "## Profit after Tax"}, {"bbox": [90, 616, 1563, 712], "category": "Text", "text": "The profit after tax of the company increased from ₹ 3444.47 lakhs in the Fiscal 2024 to ₹ 2813.09 lakhs in the Fiscal 2025 representing a decrease of 18.33%. The decrease in the PAT was the resultant of the accounting of losses of associate company on exit."}, {"bbox": [90, 744, 1304, 778], "category": "Section-header", "text": "## Comparison of Financial Year 2024 with Financial Year 2023 (Based on Restated Financial Statements)"}, {"bbox": [90, 809, 253, 840], "category": "Section-header", "text": "### Total Income"}, {"bbox": [90, 872, 1563, 971], "category": "Text", "text": "Our total income has increased by 11.71% to ₹ 20644.71 lakhs in Fiscal 2024 from ₹ 18481.15 lakhs in Fiscal 2023. The total income has increased as the revenue of the company has increased by 11.44% due to the increase in the manufacturing and trading of products of the company. Also the other income of the company has witnessed the growth of 35.02%."}, {"bbox": [90, 1001, 405, 1035], "category": "Section-header", "text": "### Revenue from Operations"}, {"bbox": [90, 1064, 1563, 1162], "category": "Text", "text": "Our Revenue from operations has increased very insignificantly by 11.44% to ₹ 20364.61 lakhs in Fiscal 2024 from ₹ 18273.63 lakhs in Fiscal 2023. The revenue has increased of the company as it has increased by 11.44% due to the increase in the production of reagent and medical devices of the company."}, {"bbox": [90, 1192, 262, 1223], "category": "Section-header", "text": "### Other Income"}, {"bbox": [90, 1255, 1563, 1321], "category": "Text", "text": "Our other income was ₹ 207.52 lakhs in Fiscal 2023, which has increased by 35.02% to ₹ 280.20 lakhs in Fiscal 2024. The main reason for such increase is the increased interest income of the company and profit on sale of PPE."}, {"bbox": [90, 1353, 207, 1386], "category": "Section-header", "text": "### Expenses"}, {"bbox": [90, 1416, 1563, 1546], "category": "Text", "text": "Our total expenses have increased by 13.47% to ₹ 17584.65 lakhs in Fiscal 2024 from ₹ 15497.15 lakhs in Fiscal 2023. The main reason for increase is the increase in Cost of goods sold which increased from 18.16% of total income to 23.33% in the financials year 24, the change in the cost of goods sold is due to the product mix of the company. Also the finance cost and depreciation expenses increased by 39.71% and 44.19% respectively."}, {"bbox": [90, 1576, 318, 1607], "category": "Section-header", "text": "### Cost of Goods sold"}, {"bbox": [90, 1638, 1563, 1705], "category": "Text", "text": "The cost of goods sold increased from ₹ 2683.27 lakhs to 3429.25 lakhs representing an increase of approximately 27.80%. The main reason for increase in the cost of goods sold was due to the production and trading of the company products."}, {"bbox": [90, 1737, 423, 1770], "category": "Section-header", "text": "### Employee benefits expenses"}, {"bbox": [90, 1799, 971, 1832], "category": "Text", "text": "Employee benefit expenses remained constant of the company over the period."}, {"bbox": [90, 1864, 570, 1896], "category": "Section-header", "text": "### Depreciation and amortization expenses"}, {"bbox": [90, 1928, 1563, 1993], "category": "Text", "text": "Depreciation, and amortization expenses increased by 83.75% from ₹ 213.75 lakhs in Fiscal 2023 to ₹ 392.77 lakhs in Fiscal 2024. The increase is attributable to the increase in the capex by the company which has seen significant growth over the period."}, {"bbox": [90, 2023, 279, 2057], "category": "Section-header", "text": "## Other expenses"}]